In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

According to the paper by researchers at the University of Bath in the UK and Lund University in Sweden, the self-regulated ...

Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...

In conclusion, I see 2025 as a year in which the patient will still be centre-stage. But, in order for that to happen ...

GSK is reportedly in late-stage negotiations about a $1 billion deal to acquire IDRx and its experimental targeted therapy ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which ...